MINAPHARM Pharmaceuticals - Cash Flow Statement (TTM)

MINAPHARM Pharmaceuticals
EG ˙ CASE
Cash Flow Statement (TTM)

MINAPHARM Pharmaceuticals Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Cash From Operating Activities 487 437 359 442 281 207 393 349 429 562 450 330 217 102 95 231 160 222 13
Change (%) -10.23 -17.94 23.32 -36.58 -26.12 89.39 -11.02 22.79 30.97 -19.81 -26.69 -34.42 -52.75 -6.91 142.99 -30.91 38.50 -94.27
% of Cash Flow 272.16 173.13 154.17 173.64 188.16 -498.76 114.03 214.05 224.00 78.95 96.34 78.95 66.87 45.62 6.55 14.70 9.77 22.85 -1.97
Cash From Investing Activities -163 -148 -183 -204 -268 -389 -472 -683 -872 -1,162 -1,594 -1,642 -1,592 -1,405 -992 -944 -605 -574 -540
Change (%) -9.68 24.22 11.18 31.57 45.07 21.31 44.86 27.65 33.22 37.16 3.00 -3.04 -11.73 -29.37 -4.92 -35.90 -5.14 -5.96
% of Cash Flow -91.30 -58.44 -78.78 -79.99 -179.80 935.87 -137.05 -418.80 -455.60 -163.34 -340.94 -392.54 -491.57 -626.41 -68.28 -59.91 -36.96 -59.19 83.72
Cash From Financing Activities -106 -27 72 30 127 156 367 456 599 994 1,318 1,410 1,387 1,296 2,180 2,143 1,744 1,316 -143
Change (%) -74.67 -368.43 -57.74 319.15 22.43 135.96 24.13 31.54 65.87 32.62 6.91 -1.63 -6.51 68.12 -1.70 -18.61 -24.52 -110.90
% of Cash Flow -58.97 -10.59 30.83 11.90 85.22 -374.34 106.63 279.21 313.01 139.72 281.97 336.97 428.13 577.88 149.94 136.02 106.54 135.77 22.25
Cash Flow 179 252 233 255 149 -42 344 163 191 712 468 418 324 224 1,454 1,575 1,637 969 -645
Change (%) 41.12 -7.85 9.49 -41.47 -127.87 -928.36 -52.60 17.34 271.60 -34.29 -10.54 -22.57 -30.73 547.95 8.36 3.91 -40.77 -166.49
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista